Hyperinsulinemia or Insulin Resistance: What Impacts the Progression of Alzheimer’s Disease?-Reference-Cited by-同舟云学术

Hyperinsulinemia or Insulin Resistance: What Impacts the Progression of Alzheimer’s Disease?

Published:2019-12-27 Issue:s1 Volume:72 Page:S71-S79
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Hegde Vijay¹,Dhurandhar Nikhil V.¹,Reddy P. Hemachandra²

Affiliation:

1. Obesity and Metabolic Health Laboratory, Department of Nutritional Sciences Texas Tech University, Lubbock, TX, USA

2. Internal Medicine, Cell Biology and Biochemistry, Neuroscience/Pharmacology and Neurology, Texas Tech University Health Sciences Center, Lubbock, TX, USA

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference109 articles.

1. Alzheimer’s disease;Ballard;Lancet,2011

2. Recent global trends in the prevalence and incidence of dementia, and survival with dementia;Prince;Alzheimers Res Ther,2016

3. Role of genes and environments for explaining Alzheimer disease;Gatz;Arch Gen Psychiatry,2006

4. Alzheimer’s disease: The challenge of the second century;Holtzman;Sci Transl Med,2011

5. Brain aging, Alzheimer’s disease, and mitochondria;Swerdlow;Biochim Biophys Acta,2011

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of Antidiabetic Effects of Medicinal Plants: A Systematic Review;Current Traditional Medicine;2024-08-26

2. Revealing genomic heterogeneity and commonality: A penalized integrative analysis approach accounting for the adjacency structure of measurements;Genetic Epidemiology;2024-02-05

3. Brain insulin resistance and Alzheimer’s disease: a systematic review;Dementia & Neuropsychologia;2024

4. Upregulation of Pin1 contributes to alleviation of cognitive dysfunction in diabetic mice;Brain and Behavior;2023-11-21

5. Correlations between insulin-degrading enzyme and metabolic markers in patients diagnosed with type 2 diabetes, Alzheimer’s disease, and healthy controls: a comparative study;Endocrine;2023-11-18